Epilepsy breakthrough for Adelaide researchers
11 March, 2002 by Melissa TrudingerA surprise finding by a team of Adelaide scientists has provided the first evidence that the same gene on the X-chromosome may be responsible for some forms of both epilepsy and intellectual disability.
FDA approves Sirtex cancer treatment
08 March, 2002 by Iain ScottSydney company Sirtex Medical's novel liver cancer treatment has been approved by the US Food and Drug Administration (FDA), opening the door to what the company says is a billion dollar market.
Diabetes project sets new trend for NHMRC
06 March, 2002 by Daniella GoldbergThe National Health and Medical Research Council (NHMRC) has come up with a new model for commercialising medical research.
Tumour barcode spells hope for better cancer diagnosis
19 February, 2002 by Tanya HollisCancer patients could face improved diagnoses and survival rates with the development of a tumour barcode.
Prima in high-level licensing talks
18 February, 2002 by Tanya HollisPrima BioMed has commenced preliminary talks with several major drug companies over potential licensing options for its new anti-inflammatory compound,VIB 153.
